Additionally, Hiroto Takeya et al. revealed a positive association between higher CD169 expression and density of tumor-infiltrating lymphocytes in esophageal cancer who underwent neoadjuvant chemotherapy, indicating that high CD169 expression plays a crucial role in inducing anti-cancer immune responses [19]. The gene discussed is SIGLEC1; the disease is cancer.